Novo Nordisk Boasts Strong Diabetes Presence and Pipeline

Novo Nordisk has a strong presence in the Diabetes care market with a global value market share of 28%. Also, the company has strong presence in the total insulin market, and modern and new-generation insulin market with a global value market share of 46 https://www.nasdaq.com/article/novo-nordisk-boasts-strong-diabetes-presence-and-pipeline-cm1076966